Literature DB >> 18824314

Non-invasive ventilation of the preterm infant.

Eduardo Bancalari1, Nelson Claure.   

Abstract

Non-invasive ventilation (NIV) is increasingly being used in preterm infants with the purpose of reducing the risk of adverse pulmonary outcome associated with invasive mechanical ventilation. This review analyzes the evidence from physiologic and clinical studies on the use of NIV in the preterm infant. Physiologic data indicate advantages of NIV with regard to ventilation, gas exchange, breathing effort and thoraco-abdominal distortion. Data from clinical trials have consistently shown facilitation of weaning from mechanical ventilation and potential benefits in infants with RDS and apnoea. Long term improvements in respiratory outcome have also been reported but need to be confirmed in larger trials.

Entities:  

Mesh:

Year:  2008        PMID: 18824314     DOI: 10.1016/j.earlhumdev.2008.09.010

Source DB:  PubMed          Journal:  Early Hum Dev        ISSN: 0378-3782            Impact factor:   2.079


  6 in total

1.  Fatty acid-binding proteins and peribronchial angiogenesis in bronchopulmonary dysplasia.

Authors:  Elisa Ghelfi; Cagatay Karaaslan; Sara Berkelhamer; Serra Akar; Harry Kozakewich; Sule Cataltepe
Journal:  Am J Respir Cell Mol Biol       Date:  2010-12-22       Impact factor: 6.914

2.  Facial skin breakdown in patients with non-invasive ventilation devices: report of two cases and indications for treatment and prevention.

Authors:  Michele Maruccia; Martina Ruggieri; Maria G Onesti
Journal:  Int Wound J       Date:  2013-07-22       Impact factor: 3.315

3.  Prolonged respiratory support of any type impacts outcomes of extremely low birth weight infants.

Authors:  Huayan Zhang; Kevin Dysart; Douglas E Kendrick; Lei Li; Abhik Das; Susan R Hintz; Betty R Vohr; Barbara J Stoll; Rosemary D Higgins; Leif Nelin; David P Carlton; Michele C Walsh; Haresh Kirpalani
Journal:  Pediatr Pulmonol       Date:  2018-07-30

4.  Noninvasive Ventilation for Preterm Twin Neonates with Respiratory Distress Syndrome: A Randomized Controlled Trial.

Authors:  Long Chen; Li Wang; Jie Li; Nan Wang; Yuan Shi
Journal:  Sci Rep       Date:  2015-09-24       Impact factor: 4.379

Review 5.  Aerosol Delivery of Lung Surfactant and Nasal CPAP in the Treatment of Neonatal Respiratory Distress Syndrome.

Authors:  Frans J Walther; Alan J Waring
Journal:  Front Pediatr       Date:  2022-06-15       Impact factor: 3.569

6.  Late administration of surfactant replacement therapy increases surfactant protein-B content: a randomized pilot study.

Authors:  Roberta L Keller; Jeffrey D Merrill; Dennis M Black; Robin H Steinhorn; Eric C Eichenwald; David J Durand; Rita M Ryan; William E Truog; Sherry E Courtney; Philip L Ballard; Roberta A Ballard
Journal:  Pediatr Res       Date:  2012-10-04       Impact factor: 3.756

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.